Lieber Jonathan I
Lieber Jonathan I, CFO, reported a transaction classified as exercise at Rallybio Corp involving 3910.000000 shares for an estimated $23772.80. Reported holdings after the transaction were 13650.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 09, 2026
- Filing date
- Oct 13, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
RLYB price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001193125-26-420562 Common Stock
- Transaction date
- Oct 09, 2026 Filed Oct 13, 2026, 08:50 PM · 4d delay
- Shares
- 3,910 sh $6.08 per share
- Estimated value
- $23.7k Computed from shares × price
- Holdings after
- 13,650 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Financial Officer
- F1
The option is granted under the Company's 2021 Equity Incentive Plan. The option vests in 48 equal monthly installments until fully vested on February 14, 2029.
0 other transactions
0 recent txs